Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Drug Interaction Study With Dapagliflozin and Metformin in Healthy Subjects

NCT00546741 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00546741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00546741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Drug Interaction Study With Dapagliflozin and Metformin in Healthy Subjects
Lead sponsor
AstraZeneca
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2007
Completion date
February 29, 2008
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy male and female subjects